BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240709T130000
DTEND;TZID=America/New_York:20240709T140000
DTSTAMP:20260501T073138
CREATED:20240618T174132Z
LAST-MODIFIED:20240618T174132Z
UID:34203-1720530000-1720533600@rethinkingclinicaltrials.org
SUMMARY:The Science of Partner Engagement in Research: Development and Validation of Evaluation Metrics
DESCRIPTION:Melody S. Goodman\, Ph.D.\nNew York University School of Global Public Health \nRegister for the webinar \nAbout the Webinar\nPartner engagement is a crucial part of participatory public health research\, yet the measurement of partner engagement in research is varied\, inconsistent\, and not methodologically sound. Partner-engaged research approaches and a mixed-methods (qualitative/quantitative) study design are used to validate a measure to assess the level of partner engagement in research—the research engagement survey tool (REST). To reduce partner burden\, a brief nine-item version of REST was developed. The resulting comprehensive version of REST was narrowed to 32 items corresponding to eight engagement principles. Psychometric results show acceptable internal consistency for the revised comprehensive measure’s eight engagement principles\, both on the quality and quantity scale (Cronbach’s Alpha from 0.79 to 0.92). Results also show low to moderate correlative validity with similar measures (Spearman correlation coefficient range: 0.19 to 0.69). Results show promise for a nine-item brief version of REST that is highly correlated with the comprehensive version of REST (quality and quantity: r=0.97\, p<0.01) and has similar overall and engagement principle-specific means. \nAbout Melody S. Goodman\nDr. Melody Goodman received her B.S. summa cum laude in applied mathematics-statistics and economics from Stony Brook University. She received her M.S. in biostatistics from the Harvard T.H. Chan School of Public Health and her Ph.D. from the Department of Biostatistics at Harvard University with minors in theoretical statistics and the social determinants of health disparities. She is the Senior Executive Vice Dean\, Professor of Biostatistics\, and Director of the Center for Anti-Racism\, Social Justice & Public Health at the New York University School of Global Public Health. Her research interest is identifying the origins of health inequities and developing evidence-informed primary prevention strategies to reduce these health inequities. NIH\, Robert Wood Johnson Foundation\, Verizon Foundation\, Long Island Community Foundation\, Patient-Centered Outcomes Research Institute\, and Susan G. Komen for the Cure have all funded her work. Dr. Goodman has over 100 peer-reviewed journal articles and two books (2018 Routledge/Taylor & Francis Group)—Public Health Research Methods for Partnerships and Practice\, and Biostatistics for Clinical and Public Health Research. She is a Fellow of the American Statistical Association (2021) and the inaugural recipient of the Societal Impact Award from the Caucus for Women in Statistics (2021). \nDr. Goodman is a biostatistician and research methodologist. Her research efforts seek to develop a more rigorous understanding of the social risk factors that contribute to health inequities in urban areas\, intending to develop culturally competent\, region-specific solutions through collaborative activities with community members\, community-based organizations\, faith-based organizations\, and other community health stakeholders. The purpose of this work is not to continue to identify problems; rather\, her work focuses on developing solutions for improving health in minoritized and medically underserved communities. Dr. Goodman has two primary lines of research—an applied methods track that conducts applied biostatistical and survey research for community-based interventions and health inequities research with a strong focus on measurement\, and a community-engaged research track with a focus on enhancing the infrastructure for community-engaged research through academic-community collaborations\, as well as the implementation and evaluation of community-engaged research projects to reduce health inequities.
URL:https://rethinkingclinicaltrials.org/event/the-science-of-partner-engagement-in-research-development-and-validation-of-evaluation-metrics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240712T130000
DTEND;TZID=America/New_York:20240712T140000
DTSTAMP:20260501T073138
CREATED:20240625T180805Z
LAST-MODIFIED:20240626T133226Z
UID:34265-1720789200-1720792800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 12\, 2024: Causal Estimands: Should We Ask Different Causal Questions in Randomized Trials and in the Observational Studies That Emulate Them? (Miguel Hernan\, MD)
DESCRIPTION:Speaker: \nMiguel Hernan\, MD\nProfessor of Biostatistics and Epidemiology\nCAUSALab\nHarvard T.H. Chan School of Public Health \nTitle: Causal Estimands: Should We Ask Different Causal Questions in Randomized Trials and in the Observational Studies That Emulate Them? \nDate: Friday\, July 12\, 2024\, 1:00-2:00 pm ET \nTo join the online meeting: \n\nhttps://duke.zoom.us/j/99172752012?pwd=UzBTWE5laW8yOE42c2xTVVFuZmc3QT09\nMeeting ID: 991 7275 2012\nPasscode: 349220\n\nOne tap mobile \n+13017158592\,\,99172752012#\,\,\,\,*349220# US \n+13052241968\,\,99172752012#\,\,\,\,*349220# US \nAudio only options: \n+1 309 205 3325 \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 991 7275 2012 \nPasscode: 349220
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-12-2024-causal-estimands-should-we-ask-different-causal-questions-in-randomized-trials-and-in-the-observational-studies-that-emulate-them-miguel-hernan-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240715T130000
DTEND;TZID=America/New_York:20240715T160000
DTSTAMP:20260501T073138
CREATED:20240618T143319Z
LAST-MODIFIED:20240618T144547Z
UID:34189-1721048400-1721059200@rethinkingclinicaltrials.org
SUMMARY:Virtual Workshop: Going From Zero to 100: Generating Evidence Through Pragmatic Research to Address Pressing Healthcare Issues
DESCRIPTION:The NIH Pragmatic Trials Collaboratory’s virtual workshop will explore how to generate meaningful\, actionable evidence through pragmatic research. \nJoin the Videocast: https://videocast.nih.gov/watch=54927 \nDay 1: July 15\, 1:00 pm–4:00 pm ET \n\nPhase Zero: Getting the Research Question Right\nEngagement as the Cornerstone in Pragmatic Research\n\nView the workshop flyer for detailed information and to register.
URL:https://rethinkingclinicaltrials.org/event/virtual-workshop-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240716T110000
DTEND;TZID=America/New_York:20240716T153000
DTSTAMP:20260501T073138
CREATED:20240618T144142Z
LAST-MODIFIED:20240618T144443Z
UID:34191-1721127600-1721143800@rethinkingclinicaltrials.org
SUMMARY:Virtual Workshop: Going From Zero to 100: Generating Evidence Through Pragmatic Research to Address Pressing Healthcare Issues
DESCRIPTION:The NIH Pragmatic Trials Collaboratory’s virtual workshop will explore how to generate meaningful\, actionable evidence through pragmatic research. Day 2 will feature a keynote by NIH Director Dr. Monica Bertagnolli. \nJoin the Videocast: https://videocast.nih.gov/watch=54928 \nDay 2: July 16\, 11:00 am–3:30 pm ET \n\nKeynote: How Do We Identify the High-Priority Healthcare Issues That Require the Effort\, Time\, and Funding of a Trial?\nScaling to 100: How to Use Data From Disparate Data Systems\nPhase Zero: Retrofitting\, Reimagining\, and Redesigning Healthcare Systems to Reach Populations Most Affected by Health Inequities\nScaling to 100: Overcoming Administrative Burden in Pragmatic Research\n\nView the workshop flyer for detailed information and to register.
URL:https://rethinkingclinicaltrials.org/event/virtual-workshop-2024-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240719T130000
DTEND;TZID=America/New_York:20240719T140000
DTSTAMP:20260501T073138
CREATED:20240710T194340Z
LAST-MODIFIED:20240715T135943Z
UID:34355-1721394000-1721397600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 19\, 2024: Lessons From PRECIDENTD: A Pragmatic Comparative Effectiveness Trial (Brendan M Everett\, MD\, MPH; Deborah J. Wexler\, MD\, MSc)
DESCRIPTION:Speakers: \nBrendan M. Everett\, MD\, MPH\nAssociate Professor of Medicine\nDivisions of Cardiology and Preventive Medicine\nBrigham and Women’s Hospital and Harvard Medical School \nDeborah J. Wexler\, MD\, MSc\nAssociate Professor of Medicine and Diabetes Unit Chief\nMassachusetts General Hospital and Harvard Medical School \nTitle: Lessons From PRECIDENTD: A Pragmatic Comparative Effectiveness Trial \nDate: Friday\, July 19\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/99288054501?pwd=S05hU2dFUmxzUXY1ZUJweXc1UXBOdz09 \nMeeting ID: 992 8805 4501\nPasscode: 297767 \nOne tap mobile \n+13126266799\,\,99288054501#\,\,\,\,*297767# US \n+16468769923\,\,99288054501#\,\,\,\,*297767# US \nAudio Only Options \n\n+1 309 205 3325 (US)\nInternational: https://duke.zoom.us/u/acGjMcvNR6\n\nMeeting ID: 992 8805 4501\nPasscode: 297767
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-19-2024-lessons-from-precidentd-a-pragmatic-comparative-effectiveness-trial-brendan-m-everett-md-mph-deborah-j-wexler-md-msc/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240726T130000
DTEND;TZID=America/New_York:20240726T140000
DTSTAMP:20260501T073138
CREATED:20240626T133622Z
LAST-MODIFIED:20240723T215808Z
UID:34268-1721998800-1722002400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 26\, 2024: Interventions for Optimization of Guideline-Directed Medical Therapy (Gregg C. Fonarow\, MD)
DESCRIPTION:Speaker: \nGregg C. Fonarow\, MD\, FACC\, FAHA\, FHFSA\nEliot Corday Professor of Cardiovascular Medicine and Science\nDirector\, Ahmanson-UCLA Cardiomyopathy Center\nCodirector\, UCLA Preventative Cardiology Program\nUCLA Division of Cardiology \nTitle: Interventions for Optimization of Guideline-Directed Medical Therapy \nDate: Friday\, July 26\, 2024\, 1:00-2:00 pm ET \nPlease click the link below to join the webinar: \nhttps://duke.zoom.us/j/92864734319?pwd=dFFrxrIlr91k0cgfeb0BFZFjCe29Hd.1\nPasscode: 019596 \nOne tap mobile : \n    +13052241968\,\,92864734319#\,\,\,\,*019596# US \n    +13092053325\,\,92864734319#\,\,\,\,*019596# US \nAudio Only Option: \n    +1 305 224 1968 US \n    +1 309 205 3325 US \nWebinar ID: 928 6473 4319 \nPasscode: 019596
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-26-2024-interventions-for-optimization-of-guideline-directed-medical-therapy-gregg-c-fonarow-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
END:VCALENDAR